Journal of Clinical Virology

Article	Citations
Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis	465
Evaluation of rapid antigen test for detection of SARS-CoV-2 virus	391
Comparison of seven commercial RT-PCR diagnostic kits for COVID-19	368
SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients	286
Evaluation of two automated and three rapid lateral flow immunoassays for the detection of anti-SARS-CoV-2 antibodies	227
Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies	216
Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: Two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immu	198
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms	186
Performance of six SARS-CoV-2 immunoassays in comparison with microneutralisation	169
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2	168
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays	163
Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2	156
Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays	139
Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients	138
Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19	135
Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic	125
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care	121
Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG	117
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis	114
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection	110
Real-time PCR-based SARS-CoV-2 detection in Canadian laboratories	96
Combination of four clinical indicators predicts the severe/critical symptom of patients infected COVID-19	96
Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2	94
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria	92
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutrali	91

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?	91
Self-collection: An appropriate alternative during the SARS-CoV-2 pandemic	90
Evaluation of rapid diagnosis of novel coronavirus disease (COVID-19) using loop-mediated isothermal amplification	89
Characterisation of COVID-19 Pandemic in Paediatric Age Group: A Systematic Review and Meta-Analysis	88
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus	87
Evidence and possible mechanisms of rare maternal-fetal transmission of SARS-CoV-2	86
Clinical evaluation of an immunochromatographic IgM/IgG antibody assay and chest computed tomography for the diagnosis of COVID-19	85
SARS-CoV-2 detection by direct rRT-PCR without RNA extraction	83
High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2	83
Multi-Stage Group Testing Improves Efficiency of Large-Scale COVID-19 Screening	83
Evaluation of the COVID19 ID NOW EUA assay	80
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies	78
Performance evaluation of Abbott ARCHITECT SARS-CoV-2 IgG immunoassay in comparison with indirect immunofluorescence and virus microneutralization test	78
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect	74
Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials	73
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests	73
A combined oropharyngeal/nares swab is a suitable alternative to nasopharyngeal swabs for the detection of SARS-CoV-2	70
Identification of multiple large deletions in ORF7a resulting in in-frame gene fusions in clinical SARS-CoV-2 isolates	70
Comparison of commercial realtime reverse transcription PCR assays for the detection of SARS-CoV-2	69
Rapid and sensitive detection of SARS-CoV-2 RNA using the Simplexa™ COVID-19 direct assay	68
Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays	68
Multiplex detection and dynamics of IgG antibodies to SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV	66
Comparison of commercial lateral flow immunoassays and ELISA for SARS-CoV-2 antibody detection	65
Epidemiological and clinical features of 200 hospitalized patients with corona virus disease 2019 outside Wuhan, China: A descriptive study	64
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection	63
Validation of SARS-CoV-2 detection across multiple specimen types	63
SARS-CoV-2-IgG response is different in COVID-19 outpatients and asymptomatic contact persons	60
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis	60
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients	58
Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2	58
Saliva sampling for diagnosing SARS-CoV-2 infections in symptomatic patients and asymptomatic carriers	57
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2	56
Persistent detection of SARS-CoV-2 RNA in patients and healthcare workers with COVID-19	56
Comparison of SARS-CoV-2 serological tests with different antigen targets	56
Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: co-infection and clinical outcomes	55
SARS-CoV-2 viral load assessment in respiratory samples	53
Pooling of SARS-CoV-2 samples to increase molecular testing throughput	52
Clinical evaluation of a SARS-CoV-2 RT-PCR assay on a fully automated system for rapid on-demand testing in the hospital setting	52
Evaluation of simple nucleic acid extraction methods for the detection of SARS-CoV-2 in nasopharyngeal and saliva specimens during global shortage of extraction kits	52
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody	51
Analysis of Covid-19 and non-Covid-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan	51
Clinical evaluation of five different automated SARS-CoV-2 serology assays in a cohort of hospitalized COVID-19 patients	51
Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis	49
Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study	49
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance	48
Modeling the effects of intervention strategies on COVID-19 transmission dynamics	48
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure	48
Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting	47
Another false-positive problem for a SARS-CoV-2 antigen test in Japan	47
A predictive tool for identification of SARS-CoV-2 PCR-negative emergency department patients using routine test results	47

Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test	47
Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: A prospective longitudinal study	46
Maternal type of CMV infection and sequelae in infants with congenital CMV: Systematic review and meta-analysis	46
Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay	46
Implementation of rapid SARS-CoV-2 antigenic testing in a laboratory without access to molecular methods: Experiences of a general hospital	46
Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance	45
SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus	45
Evaluation of the commercially available LightMix® Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection	45
Comparison of different serological assays for SARS-CoV-2 in real life	44
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort	44
Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus.	43
Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detect	40
Alltest rapid lateral flow immunoassays is reliable in diagnosing SARS-CoV-2 infection from 14 days after symptom onset: A prospective single-center study	40
Evaluation of the RealStar® SARS-CoV-2 RT-PCR kit RUO performances and limit of detection	39
A RT-PCR assay for the detection of coronaviruses from four genera	38
Comparison of a laboratory-developed test targeting the envelope gene with three nucleic acid amplification tests for detection of SARS-CoV-2	38
First results of a national external quality assessment scheme for the detection of SARS-CoV-2 genome sequences	38
Single-step RT-PCR assay for dual genotyping of GI and GII norovirus strains	38
Improved diagnosis of viral encephalitis in adult and pediatric hematological patients using viral metagenomics	38
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR	37
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)	36
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay	36
Clinical predictors and timing of cessation of viral RNA shedding in patients with COVID-19	36
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.	34
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples	34
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19	34
Detection of low levels of SARS-CoV-2 RNA from nasopharyngeal swabs using three commercial molecular assays	34
Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR	34
SARS-CoV-2 antibody screening in healthcare workers in a tertiary centre in North West England	33
Nosocomial outbreak of SARS-CoV-2 infection in a haematological unit – High mortality rate in infected patients with haematologic malignancies	33
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study	33
Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection	33
Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness	33
Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection	33
Human Calicivirus Typing tool: A web-based tool for genotyping human norovirus and sapovirus sequences	32
Five-minute point-of-care testing for SARS-CoV-2: Not there yet	32
Evaluation of nCoV-QS (MiCo BioMed) for RT-qPCR detection of SARS-CoV-2 from nasopharyngeal samples using CDC FDA EUA qPCR kit as a gold standard: An example of the need of validation studies	32
Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: A national perspective from the pediatric Spanish Society (AEP).	31
Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures	31
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants	31
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design	30
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domai	30
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility	30
Human coronaviruses: Origin, host and receptor	29
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge	29
Evaluation of the Aptima™ transcription-mediated amplification assay (Hologic®) for detecting SARS-CoV-2 in clinical specimens	29
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection	29
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2	28
Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections	28
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19	27
Rapid implementation and validation of a cold-chain free SARS-CoV-2 diagnostic testing workflow to support surge capacity	27
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?	27
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant	27
Coronavirus disease 2019 in children: Characteristics, antimicrobial treatment, and outcomes	26
Clinical evaluation of AusDiagnostics SARS-CoV-2 multiplex tandem PCR assay	26
Human Bocavirus infection and respiratory tract disease identified in a UK patient cohort	26
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7	26
Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection	25
Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19	25
Correlation between monkeypox viral load and infectious virus in clinical specimens	25
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory	25
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommen	25
Dynamics of IgG-avidity and antibody levels after Covid-19	24
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	24
RSV reemergence in Argentina since the SARS-CoV-2 pandemic	24
Rapid screening method for the detection of SARS-CoV-2 variants of concern	24
Evolution of awareness and knowledge of congenital cytomegalovirus infection among health care providers in France between 2011 and 2018	23
Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?	23
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain	22
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection	22
Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays	22
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers	22
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay	22
Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients	22
Rapid and simultaneous identification of three mutations by the Novaplex™ SARS-CoV-2 variants I assay kit	22
Improved oral detection is a characteristic of Omicron infection and has implications for clinical sampling and tissue tropism	21
Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity	21
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020	21
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)	21
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design	21

Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response	20
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing	20
Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples	20
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens	20
Multicenter evaluation of the NeuMoDx™ SARS-CoV-2 Test	20
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis	20
SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.	19
Comparative evaluation of SARS-CoV-2 IgG assays in India	19
Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study	19
Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis	19
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study	19
Redondovirus DNA in human respiratory samples	18
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department	18
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control	18
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2	18
Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory	18
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study	18
Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults	17
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus	17
Assessing the burden of viral co-infections in acute gastroenteritis in children: An eleven-year-long investigation	17
The diagnosis of pandemic coronavirus pneumonia: A review of radiology examination and laboratory test	17
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting	17
Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument	17
The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China	16
Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation	16
Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR	16
SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia	16
Human adenovirus species in children with acute respiratory illnesses	16
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays	16
Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay	16
Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients	16
Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014-2017 seasons in Barcelona, Spain	16
Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)	16
A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay	15
SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility	15
Case fatality rate in patients with COVID-19 infection and its relationship with length of follow up	15
Evaluation of sixteen ELISA SARS-CoV-2 serological tests	15
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses	15
Archetype JC polyomavirus DNA associated with extracellular vesicles circulates in human plasma samples	15
Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection	15
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting	15
Droplet digital PCR quantification suggests that higher viral load correlates with improved survival in HPV-positive oropharyngeal tumours	15